| 1 | ASIP, CDK4, CDKN2A, CMM1, CMM2, CMM20, CMM3, CMM4, MC1R, TYR, TYRP1
|
| Genetic risk factors for melanoma.
|
| Meyle KD, Guldberg P.
|
| Hum Genet 126(4):499-510. Epub 2009 Jul 8. Review.
2009
|
| 2 | CDK4, CMM3
|
| A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation.
|
| Molven A, Grimstvedt MB, Steine SJ, Harland M, Avril MF, Hayward NK, Akslen LA.
|
| Genes Chromosomes Cancer 44(1):10-8. 2005
|
| 3 | CDK4, CDKN2A, CMM3
|
| Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France.
|
| Soufir N, Avril MF, Chompret A, Demenais F, Bombled J, Spatz A, Stoppa-Lyonnet D, Benard J, Bressac-de Paillerets B.
|
| Hum Mol Genet 7(2):209-16. 1998
|
| 4 | CDK4, CMM3
|
| Complete scanning of the CDK4 gene by denaturing gradient gel electrophoresis: a novel missense mutation but low overall frequency of mutations in sporadic metastatic malignant melanoma.
|
| Guldberg P, Kirkin AF, Gronbaek K, thor Straten P, Ahrenkiel V, Zeuthen J.
|
| Int J Cancer 72(5):780-3. 1997
|
| 5 | CDK4, CMM3
|
| Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma.
|
| Zuo L, et al.
|
| Nat Genet 12 : 97-99. 1996
|
| 6 | CDK4, CMM3
|
| A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma.
|
| Wšlfel T, et al.
|
| Science 269 : 1281-1284. 1995
|